Novelix Pharmaceuticals Ltd — Important, 21-10-2025: Company Update

Novelix Pharmaceuticals announced its compliance for the quarter ended September 30 regarding share dematerialization. The company's Registrar and Share Transfer Agent confirmed that all physical securities received for conversion into electronic format were thoroughly verified, cancelled, and then registered with depositories NSDL and CDSL within the stipulated 15-day period. This regular update assures investors that shareholder records are accurately maintained and that the transition of physical shares to electronic format is handled efficiently. It's a key process for ensuring market integrity and smooth trading of the company's shares.